Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor [Phase 4]
Phase 4 study comparing tocilizumab (RoActemra) versus adalimumab, both with methotrexate, in patients with moderate to severe rheumatoid ar…
-
CLINICAL_TRIALS trial_result · 2014-02-07Clinical Trial Update: Study of Different Doses of Folic Acid in Combination With Methotrexate in Rheumatoid Arthritis [Phase 4]
This is a Phase 4 clinical trial evaluating different doses of folic acid in combination with methotrexate for rheumatoid arthritis. The stu…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate [Phase 1]
This Phase 1 study update assesses the pharmacokinetics, pharmacodynamics, safety and tolerability of ASP2408 after multiple subcutaneous do…
-
CLINICAL_TRIALS trial_result · 2014-02-05Clinical Trial Update: Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA) [Phase 3]
A Phase 3 trial update reports MRI-verified early response to certolizumab pegol in subjects with active rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb [Phase 1]
Phase 1 pharmacokinetic study comparing abatacept produced at Lonza Biologics with abatacept produced at Bristol-Myers Squibb's Devens facil…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue Outcomes [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled trial evaluating the oral IL-12/23 inhibitor STA-5326 Mesylate in active rheumatoid a…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED) [Phase 2]
Phase 2 study of the investigational drug MK-0873-012 in rheumatoid arthritis has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China
A post-marketing observational study assessed the real-world effectiveness of adalimumab in Chinese patients with moderately to severely act…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid Arthritis [Phase 1]
A completed Phase 1 single ascending dose study assessed safety and tolerability of sarilumab in combination with methotrexate in Japanese p…
-
FDA approval · 2014-01-23FDA Approved: ETODOLAC — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves the original ANDA for etodolac (generic) manufactured by Zydus Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: Relaxation Response Training for the Treatment of Rheumatoid Arthritis [Phase 4]
The clinical trial update reports the completion of a Phase 4 study evaluating relaxation response training as a treatment for rheumatoid ar…
-
FDA approval · 2014-01-16FDA Approved: CYCLOSPORINE — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for cyclosporine from Apotex Corp, authorizing changes under the generic product's regulatory fi…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis [Phase 2]
Phase 2 trial assessing efficacy, safety and tolerability of denosumab in rheumatoid arthritis has completed with posted results in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid Arthritis [Phase 2]
A Phase 2 long-term safety study of fostamatinib in Asian patients with rheumatoid arthritis was terminated, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Lifestyle Interventions Based on the Mediterranean Diet for Patients With Rheumatoid Arthritis [NA]
This entry reports a completed clinical trial evaluating lifestyle interventions based on the Mediterranean diet for patients with Rheumatoi…
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: Abatacept Versus Adalimumab Head-to-Head [Phase 3]
A Phase 3 head-to-head trial compared abatacept with adalimumab in rheumatoid arthritis; results were posted after completion.
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Impact of Literacy Level on Patient Education and Health Among People With Arthritis [Phase 2]
This Phase 2 trial update examines how literacy level influences patient education and health outcomes in people with arthritis, including r…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))
This clinical trial update provides follow-up results from a study of adalimumab (D2E7) for preventing joint destruction in Japanese patient…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis
A Hoffmann-La Roche–sponsored study on early rheumatoid arthritis in Algerian patients has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis [Phase 2]
Pfizer completed a Phase 2 study evaluating the efficacy and safety of SBI-087 in seropositive patients with active rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy [NA]
A completed clinical trial comparing active therapies in rheumatoid arthritis patients with active disease despite methotrexate therapy. Res…
-
CLINICAL_TRIALS research · 2013-11-28Clinical Trial Update: Group Training and Quality of Life and Reduction of Pain in Rheumatoid Arthritis Patients [NA]
This clinical trial update describes a completed study evaluating group training to improve quality of life and reduce pain in patients with…
-
CLINICAL_TRIALS research · 2013-11-25Clinical Trial Update: Effect of Fish Oil on Surgery Pain After Knee Replacement Patients: Randomized, Prospective, Double Blind, Placebo Control Trial [NA]
This clinical trial update reports a randomized, prospective, double-blind, placebo-controlled study evaluating whether fish oil reduces pos…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment
This completed clinical trial update examines how antirheumatic treatment affects endothelial function, inflammatory disease activity, and b…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 3]
A completed Phase 3 extension study evaluating the efficacy and safety of tocilizumab in adults with moderate to severe rheumatoid arthritis…